These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32413052)

  • 21. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance.
    Alame-Emane AK; Xu P; Pierre-Audigier C; Cadet-Daniel V; Shen X; Sraouia M; Siawaya JF; Takiff H; Gao Q; Gicquel B
    Int J Tuberc Lung Dis; 2015 Jun; 19(6):679-84. PubMed ID: 25946359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrazinamide susceptibility testing: proposed new standard with the BACTECTM MGITTM 960 system.
    Piersimoni C; Mustazzolu A; Iacobino A; Giannoni F; Santoro G; Gherardi G; Del Giudice A; Perna R; Fattorini L
    Int J Tuberc Lung Dis; 2016 Dec; 20(12):1677-1680. PubMed ID: 27931346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.
    Werngren J; Sturegård E; Juréen P; Ängeby K; Hoffner S; Schön T
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1253-7. PubMed ID: 22203587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of pncA mutations in multi-drug and pyrazinamide resistant Mycobacterium tuberculosis isolates cultured from Queensland migrants and Papua New Guinea residents.
    Pandey S; Lavu E; Congdon J; Moke R; Bainomugisa A; Coulter C
    Tuberculosis (Edinb); 2018 Jul; 111():109-113. PubMed ID: 30029894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing.
    Shenai S; Rodrigues C; Sadani M; Sukhadia N; Mehta A
    Indian J Tuberc; 2009 Apr; 56(2):82-90. PubMed ID: 19810590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterisation of the pncA gene in Mycobacterium tuberculosis isolates from Gauteng, South Africa.
    Bishop KS; Blumberg L; Trollip AP; Smith AN; Roux L; York DF; Kiepiela P
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):952-7. PubMed ID: 11605890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Turkey.
    Yüksel P; Tansel O
    New Microbiol; 2009 Apr; 32(2):153-8. PubMed ID: 19579692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of katG, inhA, rpoB and pncA in Mycobacterium tuberculosis isolates from MDR-TB risk patients in Thailand.
    Suthum K; Samosornsuk W; Samosornsuk S
    J Infect Dev Ctries; 2020 Mar; 14(3):268-276. PubMed ID: 32235087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Detection by Next-Generation Sequencing of Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates.
    Maningi NE; Daum LT; Rodriguez JD; Mphahlele M; Peters RP; Fischer GW; Chambers JP; Fourie PB
    J Clin Microbiol; 2015 Dec; 53(12):3779-83. PubMed ID: 26378284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
    Hong CY; Wang F; Gui J; Liu XL
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Investigation of pncA, rpsA and panD Gene Mutations Associated with Resistance in Pyrazinamide-Resistant Mycobacterium tuberculosis Isolates and Spoligotyping].
    Özgür D; Tezcan Ülger S; Kayar MB; Biçmen C; Aslantürk A; Ülger M; Aslan G
    Mikrobiyol Bul; 2022 Apr; 56(2):191-205. PubMed ID: 35477224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-
    Werngren J; Alm E; Mansjö M
    J Clin Microbiol; 2017 Jun; 55(6):1920-1927. PubMed ID: 28404681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
    Juma SP; Maro A; Pholwat S; Mpagama SG; Gratz J; Liyoyo A; Houpt ER; Kibiki GS; Mmbaga BT; Heysell SK
    BMC Infect Dis; 2019 Feb; 19(1):129. PubMed ID: 30732572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
    Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
    Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence and transmission of pyrazinamide-resistant
    Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376
    [No Abstract]   [Full Text] [Related]  

  • 36. Is sequencing better than phenotypic tests for the detection of pyrazinamide resistance?
    Bouzouita I; Cabibbe AM; Trovato A; Draoui H; Ghariani A; Midouni B; Essalah L; Mehiri E; Cirillo DM; Slim-Saidi L
    Int J Tuberc Lung Dis; 2018 Jun; 22(6):661-666. PubMed ID: 29862951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis.
    Whitfield MG; Streicher EM; Dolby T; Simpson JA; Sampson SL; Van Helden PD; Van Rie A; Warren RM
    Tuberculosis (Edinb); 2016 Jul; 99():128-130. PubMed ID: 27450014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of pyrazinamide resistance in consecutive multidrug-resistant
    Mansjo M; Werngren J; Hoffner S
    Int J Mycobacteriol; 2017; 6(2):156-161. PubMed ID: 28559517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
    Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y
    Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of pncA mutations in multidrug-resistant tuberculosis in Taiwan.
    Chiu YC; Huang SF; Yu KW; Lee YC; Feng JY; Su WJ
    BMC Infect Dis; 2011 Sep; 11():240. PubMed ID: 21910892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.